Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

PHASE3TerminatedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
FeverNeutropeniaCancer
Interventions
DRUG

ciprofloxacin and amoxicillin

PROCEDURE

Outpatient management

DRUG

i.v. antibiotics

PROCEDURE

inpatient management

Trial Locations (12)

D-53113

Pediatric Hematology/Oncology, University Children's Hospital, Bonn

D-40225

Pediatric Hematology/Oncology, University Children's Hospital, Düsseldorf

D-79106

Pediatric Hematology/Oncology, University Children's Hospital, Freiburg im Breisgau

D-80337

Pediatric Hematology/Oncology, University Children's Hospital von Hauner, Munich

D-93049

Pediatric Hematology/Oncology, University Hospital St. Hedwig, Regensburg

NL-9700

Pediatric Hematology/Oncology, University Children's Hospital, Groningen

CH-4005

Pediatric Hematology/Oncology, University Children's Hospital, Basel

CH-3010

Pediatric Hematology/Oncology, University Children's Hospital, Bern

CH-1205

Pediatric Hematology/Oncology, University Children's Hospital, Geneva

CH-1011

Pediatric Hematology/Oncology, University Children's Hospital, Lausanne

CH-6004

Pediatric Hematology/Oncology, Children's Hospital, Lucerne

CH-8032

Pediatric Hematology/Oncology, University Children's Hospital, Zurich

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Swiss Cancer League

OTHER

collaborator

Bayer

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Swiss Pediatric Oncology Group

OTHER